Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

Clinical trial NCT00007345 · COMPLETED

Trial details

NCT number: NCT00007345
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T Cell Lymphoma Peripheral T Cell Lymphoma

Start date: 2001-03-08
Primary completion: 2015-01-26
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.